United States · FDA National Drug Code directory
Tirosint
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71858-0015_4ddc8742-bf50-baa5-e063-6294a90a56eb
- Product NDC
- 71858-0015
- Form
- CAPSULE
- Composition / generic term
- levothyroxine sodium
- Labeler
- IBSA Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181201
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (71858-0015-2) / 10 CAPSULE in 1 BLISTER PACK · 71858-0015-2
- 3 BLISTER PACK in 1 CARTON (71858-0015-4) / 10 CAPSULE in 1 BLISTER PACK · 71858-0015-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →